H. Lundbeck A/S (HLUKF.OB) has partnered with OpenAI to implement ChatGPT Enterprise, providing AI capabilities to enhance decision-making and efficiency for employees. The collaboration aims to explore AI-driven use cases across research, development, and commercial functions, with ChatGPT already showing promising results in accelerating research and streamlining analysis at Lundbeck. This strategic collaboration is set to revolutionize daily workflows and free up individuals and teams from repetitive tasks, ultimately driving innovation and productivity in the pharmaceutical industry.

Read more at Nasdaq: Lundbeck Announces Adoption Of ChatGPT Enterprise; To Integrate AI Into Daily Workflows